Health Technology Assessment for Decision Making 2020

THETA Collaborative has been offering the Health Technology Assessment for Decision Making (HTA4DM) workshop since 2011. The course is a product of collaboration between THETA, the Institute of Health, Policy, Management and Evaluation (IHPME), and the Department of Medicine, University of Toronto. In the past the course has been offered at the China National Health Development Research Center (CNHDRC), Peking University, China, and at the Department of Community Health and Epidemiology, Dalhousie University, Nova Scotia. See below for course details:

Dates:

Week 1: Nov 12 & 13
Week 2: Nov 19 & 20
Week 3: Nov 26 & 27

Time: 1-5pm each session

These workshops will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-week intensive workshop will be useful to individuals who use HTA to make real-world decisions relating to drugs, devices, and programs.

Virtual workshops via Zoom: link to be sent out to registered participants.

Contact Information

Karen Liu or Ayda Zokai

email: info@theta.utoronto.ca

Registration Now Open!

Course Fee

Regular Price:  $1,200.00 CDN (including HST)

Course fee includes tuition fee, study materials, opportunities to connect with our experts.

Registration & Payment

Go to Registration page

Key Features

  • Intensive program over 6 half-days throughout a 3 week period
  • Theory bursts in lecture format to introduce and explain key concepts
  • Interactive sessions (small group learning and computer labs) to explore illustrative cases


Objectives

By the end of the course, participants will be able to review and assess:

  • Measures of evidence
  • Cost-effectiveness analyses
  • Approaches to integrating social and ethical issues


Curriculum Details

Week 1: Clinical Evidence

Day 1 will discuss HTA processes, the how and why of HTA, how HTA organizations function, as well as examine the nature of clinical evidence. Participants will learn the strengths and weaknesses of alternative study designs such as randomized controlled trials and observational research and understand how evidence strength is graded. We will also review common measures of effectiveness used in the medical literature so participants can understand the outcomes that are commonly reported in health technology assessments.

Week 2: Economic Evidence

Day 2 will explore the idea of value - the relationship between cost and health benefit. Participants will learn the key concepts and designs in cost effectiveness analysis, how to perform a simple analysis, and how to appraise and interpret cost effectiveness analyses that are part of health technology assessments.

Week 3: Social and Ethical Issues

Day 3 will explore the social and ethical issues arising in the assessment of health technologies - why these issues are important and how they can be addressed. Participants will be introduced to methods for assessing stakeholder values and preferences through research evidence or stakeholder engagement, approaches to integrating ethics and social values considerations into HTA assessments, and the decision- making and appeal processes that can improve the fairness and legitimacy of HTA decisions.

Faculty Members 2020

The Faculty Members for this year’s HTA for Decision Makers include:


Lusine Abrahamyan, PhD 
Clinical Epidemiologist, THETA; Assistant Professor, Institute of Health Policy, Management & Evaluation, University of Toronto

Murray Krahn, MD FRCPC 
Director, THETA; Senior Scientist, Toronto General Research Institute; Professor, Institute of Health Policy, Management and Evaluation, University of Toronto

Fiona Miller, PhD
Professor, Chair in Health Management Strategies, Institute of Health Policy, Management and Evaluation, University of Toronto;
Director, Health Policy and Ethics Division, THETA

Petros Pechlivanoglou, PhD 
Scientist, Child Health Evaluative Sciences (CHES), The Hospital for Sick Children, Toronto

Valeria Rac, PhD 
Scientist, Toronto General Hospital Research Institute; Associate Program Director, Director Clinical Research Division, THETA;
Assistant Professor, Institute of Health Policy, Management & Evaluation, University of Toronto

Beate Sander, PhD 
Scientist, Toronto General Hospital Research Institute;
Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto;
Adjunct Scientist, Institute for Clinical Evaluative Sciences (ICES)

Prakeshkumar Shah, MD FRCPC 
Department of Paediatrics, Mount Sinai Hospital; Associate Professor, Institute of Health Policy, Management and Evaluation, University of Toronto

HTA for Decision Making 2018: Toronto General Hospital, Toronto, Ontario

The 2018 Health Technology Assessment for Decision Making course was held on June 25-27, 2018, at the THETA Collaborative offices, Eaton Building, Toronto General Hospital 200 Elizabeth Street, Toronto. This course was again a product of collaboration between the Toronto Health Economics and Technology Assessment Collaborative (THETA), Institute of Health, Policy, Management and Evaluation, University of Toronto and Leslie Dan Faculty of Pharmacy, University of Toronto.

 Download: 2018 HTA Institute Brochure


HTA Institute 2015: University of Toronto, Toronto, Ontario

The 2015 Health Technology Assessment Institute for Decision Makers course was held on September 28-30, 2015, at the Leslie Dan Faculty of Pharmacy, University of Toronto. That year the course was a product of collaboration between the Toronto Health Economics and Technology Assessment Collaborative (THETA), Institute of Health, Policy, Management and Evaluation, University of Toronto and Leslie Dan Faculty of Pharmacy, University of Toronto.

 Download: 2015 HTA Institute Flyer


HTA Institute 2014: Halifax

July 14-16, 2014, Dalhousie University, Halifax, NS


The Canadian Agency for Drugs and Technologies in Health (CADTH), in association with the Toronto Health Economics and Technology Assessment Collaborative (THETA) and Maritime Strategy for Patient-Oriented Research Support Unit (MSSU), has offered the 2014 Health Technology Assessment for Decision Makers course. The HTA Institute brought together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course was useful to individuals who use HTA to make decisions relating to drugs, devices, and programs. The session was hosted in collaboration with:


Toronto
Institute of Health, Policy, Management and Evaluation, University of Toronto
Leslie Dan Faculty of Pharmacy, University of Toronto
Health Quality Ontario
CIHR-STIHR Health Care, Technology and Place Program
Halifax
Department of Community Health and Epidemiology, Dalhousie University
Capital District Health Authority
IWK Health Centre
Nova Scotia Health Research Foundation



HTA Institute 2013: Toronto

June 26-28, 2013 | Croft Chapter House, University College, University of Toronto
Download:
Brochure


HTA Institute 2012: China

September 12-14, 2012 | Peking University

The China National Health Development Research Center (CNHDRC) and the Toronto Health Economics and Technology Assessment Collaborative (THETA) together with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and Health Care, Technology and Place Program at the University of Toronto hosted a session of the HTA for Decision Makers in Beijing, China. The course was well received with over 50 registrants from academic, industry, and local & central governments across China.

Faculty: Ahmed Bayoumi MD MSc, Wendong Chen MD PhD, Peter Coyte PhD, Murray Krahn MD MSc, and Fiona Miller PhD
Download: Poster | Agenda | Photos
 

HTA Institute 2012: Toronto

July 25-27, 2012 | University of Toronto
Download: Brochure


HTA Institute 2011: Toronto

July 20-22, 2011 | University of Toronto
Download: Brochure